期刊文献+

多囊卵巢综合征与胰岛素抵抗和多种脂肪细胞因子的关系 被引量:6

Study on the Association of Polycystic Ovary Syndrome with Insulin Resistance and Various Adipicytokines
下载PDF
导出
摘要 多囊卵巢综合征(PCOS)是育龄期女性常见的内分泌代谢性疾病,目前认为主要与内分泌功能紊乱、下丘脑-垂体-卵巢轴调节功能异常、高胰岛素血症和胰岛素抵抗(IR)、肾上腺内分泌功能异常有关。脂肪组织不仅具有调节能量储存作用,同时还是一个内分泌器官,可分泌各种脂肪细胞因子,如脂联素、瘦素、内脂素、抵抗素、Chemerin等,这些因子通过其表达的增强或减弱不同层面参与机体内分泌代谢过程,包括能量代谢、胰岛素作用及脂类代谢等的调节,并参与肥胖、IR、血压及炎症等疾病的发生。 Polyeystic ovary syndrome(PCOS) is a heterogeneous endocrine disorder commonly found in women of reproductive age. At present, it is frequently associated with endocrine dysfunction, abnormalities of hypothalamic-pituitary-ovarian axis adjustment function, hyperinsulinemia and insulin resistance (IR), abnormalities of adrenal endocrine function. Besides, adipose tissue has been identified as an active endocrine organ that can not only store energy and regulate nutrient homeostasis but also release a large number of protein hormones ( adipokines), such as adiponectin, leptin, visfatin, resistin, chemerin, etc. By increasing or decreasing their expression, these adipokines would have effect on the endocrine and metabolic processes at different levels, including genergy metabolism, lipid metabolism and insulin regulation, and participate in the occurrence of obesity, insulin resistance, blood pressure and inflammation.
出处 《医学综述》 2014年第17期3186-3188,共3页 Medical Recapitulate
关键词 多囊卵巢综合征 胰岛素抵抗 脂肪细胞因子 肥胖 Polycystic ovary syndrome Insulin resistance Adipocytokines Obesity
  • 相关文献

参考文献38

  • 1乐杰.妇产科学[M].7版.北京:人民卫生出版社,2009:92-99.
  • 2刘世荣.多囊卵巢综合征与胰岛素抵抗关系研究进展[J].临床和实验医学杂志,2012,11(12):989-990. 被引量:3
  • 3李曌,华苓.多囊卵巢综合征胰岛素抵抗的新进展[J].国际妇产科学杂志,2011,38(4):358-363. 被引量:21
  • 4Uncu G, Ozyurek SE, Uncu Y. ACTH stimulation test in lean poly- cystic ovary syndrome patients with insulin resistance [ J ]. Fertil Steril,2007,88 ( 3 ) :670-674.
  • 5唐蓉辉,汤惠茹,王丽平,陈小琳,王玉洁,吴瑞芳.深圳市汉族育龄妇女多囊卵巢综合症患病率及临床特征分析[J].罕少疾病杂志,2010,17(1):1-5. 被引量:32
  • 6Withers DJ, Gutierrez JS,Towery H,et al. Disruption of IRS-2 cau- ses type 2 diabetes in mice [ J ]. Nature, 1998,391 ( 6670 ) : 900-904.
  • 7Withers DJ, Burks DJ, Towery HH, t al. Its-2 coordinates IGF-1 receptor-mediated beta-cell development and peripheralinsulinsig- nailing[ Jj. Nature Genet, 1999,23 ( 1 ) :32-40.
  • 8Wu XK, Zhou SY, Liu JX. Selective ovary resistance to insulin sig- naling in women with polycystie ovary syndrome E J ]. Fertil Steril, 2003,80 (4) :954-965.
  • 9Galvani V, Pretnar Hartman K, Rupreht RR, et al. Soluble tumor necrosis factor receptor(sTNFR) as a prog-nosticfactor in metano- mapafients in Slovene population [ J ]. Ptlugers Arch, 2000,440 ( 5 Suppl) :R61-R63.
  • 10Diamanti-Kandarakis E, Paterakis T, Alexandraki K, et al. Indices of low-grade chronic inflammation in polyeystic ovary syndrome and the beneficial effect of mefformin[ J]. Hum Reprod ,2006,21 ( 6 ) : 1426-1431.

二级参考文献50

  • 1姚树新.多囊卵巢综合征的彩色多普勒超声诊断[J].罕少疾病杂志,2004,11(4):58-59. 被引量:1
  • 2陈子江,赵君利,周凤荣,李媛,赵力新,马增香.济南市汉族育龄妇女PCOS患病状况的初步调查[J].现代妇产科进展,2005,14(6):442-444. 被引量:41
  • 3刘霞,覃菁.多囊卵巢综合征性不孕症的中西医结合治疗[J].中国妇幼健康研究,2007,18(1):48-51. 被引量:16
  • 4Knochenhauer ES, Key TJ, Kahsar-Miller R Prevalence of the polycystic ovary syrdrome in unselected black and white women of the Southeastem United States : A prospective study. J Clin Endocrinol Metab 1998; 83: 3078-82.
  • 5Michelmore KF, Balen AH, Dunger DB, Vessey MP. Polycystic ovaries and associated clinical and biochemical features in young women. Clin Endocrinol 1999;, 51:779-86.
  • 6Kumarapeli V, Seneviratne Rde A, Wijeyaratne CN, etct, A simple Screening Approach for Assessing Comunity Prevalence and Phenotype of Polycystic Ovary Syndrome in a Semiurban Population in Sri Lanka, American Journal of Epidemiology, Am J Epidemiol, 2008 Aug 1; 168(3):321-8.
  • 7The Rotterdam ESHRE/ASRM-sponsored RIB consensus workshop group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome(B2(B). Run Reprod, 2004, 19 (1). 41-47.
  • 8曾泽毅,主编.中华妇产科学.第2版.北京:人民卫生出版社,2007,2448-2480.
  • 9金丕焕,主编.医用统计方法.第2版.上每,复旦大学出版社,2006,9.
  • 10Carmiva E. Diagnosis of polycystic ovary syndrome: from NIH criteria to ESHRE-ASRM guidelines. Minerva Girecol, 2004, 56: 1-6.

共引文献306

同被引文献73

引证文献6

二级引证文献41

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部